Search Results

You are looking at 1 - 2 of 2 items for :

  • "trigeminal neuralgia" x
  • Refine by Access: user x
Clear All
Open access

Trigeminal neuralgia secondary to vascular compression and neurocysticercosis: illustrative case

Mao Vásquez, Luis J. Saavedra, Hector H. García, Evelyn Vela, Jorge E. Medina, Miguel Lozano, Carlos Hoyos, and William W. Lines-Aguilar

Trigeminal neuralgia (TN) is the most common type of facial pain, negatively affecting quality of life and work capacity in 34% of patients. 1 TN has a prevalence of 4–13 cases per 100,000 inhabitants 1–3 and generally affects patients older than 50 years, with a female-to-male ratio of 1.5 to 1. In primary (classic) TN, compression by vascular loops is found at the entrance of the trigeminal nerve to the brainstem. 4 , 5 In secondary TN, 6 , 7 extrinsic compression of the trigeminal nerve triggers the pain. The most common causes of extrinsic TN are

Open access

Trigeminal neuropathy after tozinameran vaccination against COVID-19 in postmicrovascular decompression for trigeminal neuralgia: illustrative case

Keisuke Onoda, Ryohei Sashida, Ren Fujiwara, Tomihiro Wakamiya, Yuhei Michiwaki, Tatsuya Tanaka, Kazuaki Shimoji, Eiichi Suehiro, Fumitaka Yamane, Masatou Kawashima, and Akira Matsuno

although many side effects of neurological involvements have been shown. 1 , 2 The complications included Bell’s palsy, 3 Guillain-Barre syndrome, 4 transverse myelitis, 5 and multiple sclerosis. 6 However, the incidence is not well known. Herein, we describe a case of acute trigeminal neuropathy after receiving a Pfizer-BioNtech vaccination (tozinameran) against SARS-CoV-2 in a patient who had undergone microvascular decompression (MVD) for trigeminal neuralgia (TN). Illustrative Case This case involves a 77-year-old woman with a medical history of